A detailed history of Principal Securities, Inc. transactions in Natera, Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 344 shares of NTRA stock, worth $55,834. This represents 0.0% of its overall portfolio holdings.

Number of Shares
344
Previous 285 20.7%
Holding current value
$55,834
Previous $36.2 Million 50.51%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 30, 2025

BUY
$117.67 - $174.0 $6,942 - $10,266
59 Added 20.7%
344 $54.5 Million
Q3 2024

Oct 28, 2024

SELL
$97.75 - $129.67 $15,737 - $20,876
-161 Reduced 36.1%
285 $36.2 Million
Q2 2024

Jul 31, 2024

BUY
$85.28 - $112.6 $5,372 - $7,093
63 Added 16.45%
446 $48.3 Million
Q1 2024

May 10, 2024

SELL
$59.21 - $92.9 $7,993 - $12,541
-135 Reduced 26.06%
383 $35 Million
Q4 2023

Feb 07, 2024

BUY
$37.55 - $62.64 $19,450 - $32,447
518 New
518 $32.4 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $15.7B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Principal Securities, Inc. Portfolio

Follow Principal Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Principal Securities, Inc. with notifications on news.